Fluvastatin Reduces Cardiac Mortality in Patients with Coronary Heart Disease

By Ballantyne Christie   Riegger Günter   Moore Nicholas   Saia Francesco   Serruys Patrick  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Sarcoplasmic reticulum and cardiac oxidative stress: an emerging target for heart disease

By Dhalla N.S.   Temsah R.M.  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 2, 2001-04 ,pp. : 205-217

Informa Healthcare

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA) and the risk for coronary heart disease: the multicenter CARDIAC study

By Lenzen Henrike   Tsikas Dimitrios   Böger Rainer  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 45-49

Springer Publishing Company

Access to resources Recommend Favorite

Granulocyte Colony Stimulating Factor in the Treatment of Cardiac Ischemic Disease. A Decade has Passed: Is it Time to Give Up?: Editorial to “Disassociation between Left Ventricular Mechanical and Electrical Properties in Ischemic Rat Heart after G-CSF Treatment“ by Liu et al.

By Louzada Ruy  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 3, 2011-06 ,pp. : 191-195

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 10, Iss. 2, 2011-04 ,pp. : 132-152

Bentham Science Publishers

Access to resources Recommend Favorite